Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 15,111 | $127.24 | $1,922,723.64 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,380,503 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 108 | $132.25 | $14,283.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,370,252 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,500 | $131.09 | $196,635.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,370,360 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,700 | $130.32 | $351,864.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,371,860 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,200 | $129.21 | $155,052.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,374,560 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,743 | $128.05 | $607,341.15 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,375,760 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 15,111 | $127.24 | $1,922,723.64 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,380,503 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive. F4 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 31, 2018 Filed Aug 3, 2018 00:03 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 100,000 | $131.50 | $13,150,000.00 |
DisclosureSEC source: 0001144204-18-041780 · tv500079_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,395,614 Read SEC document |
| July 31, 2018 Filed Aug 3, 2018 00:02 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 100,000 | $131.50 | $13,150,000.00 |
DisclosureSEC source: 0001144204-18-041779 · tv500078_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,395,614 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 27, 2018 Filed Jul 30, 2018 20:38 UTC |
Macuga Daniel A.Chief Communications Officer
|
SaleCommon Stock | 503 | $132.40 | $66,599.11 |
DisclosureSEC source: 0001179110-18-010006 · edgar.xml · nonDerivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:40 UTC |
FULLER GILBERT ADirector
|
SaleCommon Stock | 282 | $131.22 | $37,004.72 |
DisclosureSEC source: 0001179110-18-009941 · edgar.xml · nonDerivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 26, 2018 Filed Jul 27, 2018 17:38 UTC |
Winssinger Frederic JDirector
|
SaleCommon Stock | 282 | $132.75 | $37,435.50 |
DisclosureSEC source: 0001179110-18-009939 · edgar.xml · nonDerivative · entry 2 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:01 UTC |
Peng FengDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009964 · edgar.xml · derivative · entry 2 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:01 UTC |
Peng FengDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-009964 · edgar.xml · nonDerivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:40 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009941 · edgar.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% for the next four quarters. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% for the next four quarters. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:40 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-009941 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:38 UTC |
Nixon J ScottDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009940 · edgar.xml · derivative · entry 2 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:38 UTC |
Nixon J ScottDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-009940 · edgar.xml · nonDerivative · entry 1 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:38 UTC |
Winssinger Frederic JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009939 · edgar.xml · derivative · entry 3 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:38 UTC |
Winssinger Frederic JDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-009939 · edgar.xml · nonDerivative · entry 1 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:53 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 300 | $115.97 | $34,791.00 |
DisclosureSEC source: 0001144204-18-037302 · tv498024_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,495,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $115.90 to $116.00, inclusive. F6 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:53 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 8,904 | $115.42 | $1,027,699.68 |
DisclosureSEC source: 0001144204-18-037302 · tv498024_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,495,914 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $114.85 to $115.775, inclusive. F6 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 300 | $115.97 | $34,791.00 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,495,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $115.90 to $116.00, inclusive. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 23:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 8,904 | $115.42 | $1,027,699.68 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,495,914 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $114.85 to $115.775, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:53 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 13,246 | $115.35 | $1,527,926.10 |
DisclosureSEC source: 0001144204-18-037302 · tv498024_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,504,818 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $115.30 to $115.60, inclusive. F6 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:53 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 17,550 | $115.05 | $2,019,127.50 |
DisclosureSEC source: 0001144204-18-037302 · tv498024_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,518,064 F1 · price: Weighted average price. Price range in multiple transactions was $114.30 to $115.25, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 13,246 | $115.35 | $1,527,926.10 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,504,818 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $115.30 to $115.60, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 23:52 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 17,550 | $115.05 | $2,019,127.50 |
DisclosureSEC source: 0001144204-18-037301 · tv498023_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,518,064 F1 · price: Weighted average price. Price range in multiple transactions was $114.30 to $115.25, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 01:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,285 | $117.50 | $503,487.50 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,535,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.60, inclusive. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,285 | $117.50 | $503,487.50 |
DisclosureSEC source: 0001144204-18-032923 · tv495960_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,535,614 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.60, inclusive. F7 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,430 | $117.15 | $518,974.50 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,539,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $116.70 to $117.35, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 998 | $115.86 | $115,628.28 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,544,329 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.25, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 29,929 | $114.98 | $3,441,236.42 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,545,327 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $114.45 to 115.30, inclusive. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:20 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,643 | $113.99 | $529,255.57 |
DisclosureSEC source: 0001144204-18-032925 · tv495961_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,575,256 F1 · price: Weighted average price. Price range in multiple transactions was $113.45 to $114.40, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,430 | $117.15 | $518,974.50 |
DisclosureSEC source: 0001144204-18-032923 · tv495960_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,539,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $116.70 to $117.35, inclusive. F7 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 998 | $115.86 | $115,628.28 |
DisclosureSEC source: 0001144204-18-032923 · tv495960_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,544,329 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.25, inclusive. F7 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 29,929 | $114.98 | $3,441,236.42 |
DisclosureSEC source: 0001144204-18-032923 · tv495960_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,545,327 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F3 · price: Weighted average price. Price range in multiple transactions was $114.45 to 115.30, inclusive. F7 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:18 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,643 | $113.99 | $529,255.57 |
DisclosureSEC source: 0001144204-18-032923 · tv495960_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,575,256 F1 · price: Weighted average price. Price range in multiple transactions was $113.45 to $114.40, inclusive. F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,710 | $117.54 | $200,993.40 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 19 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,579,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.58, inclusive. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 7,235 | $117.40 | $849,389.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 18 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,581,609 Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 50,000 | $117.25 | $5,862,500.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 17 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,588,844 Read SEC document |
| May 31, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,710 | $117.54 | $200,993.40 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 19 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,579,899 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.58, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 31, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 7,235 | $117.40 | $849,389.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 18 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,581,609 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 31, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 50,000 | $117.25 | $5,862,500.00 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 17 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,588,844 F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,382 | $117.54 | $279,980.28 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 16 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638,844 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.625, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 17,751 | $117.26 | $2,081,482.26 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 15 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,641,226 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $116.50 to $117.475, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 25,000 | $117.00 | $2,925,000.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 14 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,658,977 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 12,537 | $115.72 | $1,450,781.64 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 13 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,683,977 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $115.50 to $116.45, inclusive. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 01:49 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 50,000 | $115.00 | $5,750,000.00 |
DisclosureSEC source: 0001144204-18-032135 · tv495643_4.xml · nonDerivative · entry 12 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696,514 Read SEC document |
| May 30, 2018 Filed Jun 6, 2018 01:15 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,382 | $117.54 | $279,980.28 |
DisclosureSEC source: 0001144204-18-032921 · tv495958_4.xml · nonDerivative · entry 16 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,638,844 F2 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $117.50 to $117.625, inclusive. F12 · ownership.nature: The holder of record of the shares of Common Stock disposed or purchased is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. The reported transactions were previously reported on a Form 4 filed on May 31, 2018 by Gull Global Limited. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.